In the BioHarmony Drug Report Database

"Preview" Icon

Zalcitabine

Hivid (zalcitabine) is a small molecule pharmaceutical. Zalcitabine was first approved as Hivid on 1992-06-19. It is used to treat acquired immunodeficiency syndrome in the USA.

 

Trade Name

 

Hivid
 

Common Name

 

zalcitabine
 

ChEMBL ID

 

CHEMBL853
 

Indication

 

acquired immunodeficiency syndrome
 

Drug Class

 

Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

Image (chem structure or protein)

Zalcitabine structure rendering